this piece corresponds to the legacy myPDB login in the form of a bootstrap modal, will likely retire-->



NVP is found in 22 entries

NVP as free ligands, exist in 22 entries. Example includes: 1LWE 4PUO 3HVT

Find related ligands: Stereoisomers Similar ligands Chemical Structure Search

View summary at Ligand Expo

Chemical Component Summary

FormulaC15 H14 N4 O
Molecular Weight266.30 g/mol
Isomeric SMILESCc1ccnc2N(C3CC3)c3ncccc3C(=O)Nc12

Chemical Details

Formal Charge0
Atom Count34
Chiral Atom Count0
Chiral Atomsn/a
Bond Count37
Aromatic Bond Count12
Leaving Atomsn/a

Drug Info: DrugBank

DrugBank IDDB00238 Different stereochemistry
DescriptionA potent, non-nucleoside reverse transcriptase inhibitor (NNRTI) used in combination with nucleoside analogues for treatment of Human Immunodeficiency Virus Type 1 (HIV-1) infection and AIDS. [PubChem] Structurally, nevirapine belongs to the dipyridodiazepinone chemical class.
  • 11-Cyclopropyl-5,11-dihydro-4-methyl-6H-dipyrido(3,2-b:2',3'-e)(1,4)diazepin-6-one
  • NEV
  • Nevirapine
  • NVP
  • Viramune
Brand Names
  • Apo-nevirapine
  • Apo-nevirapine XR
  • Apo-zidovudine-lamivudine-nevirapine
  • Auro-nevirapine
  • Mylan-nevirapi
Affected OrganismHuman Immunodeficiency Virus
IndicationFor use in combination with other antiretroviral drugs in the ongoing treatment of HIV-1 infection.
PharmacologyNevirapine is a non-nucleoside reverse transcriptase inhibitor (nNRTI) with activity against Human Immunodeficiency Virus Type 1 (HIV-1). HIV-2 RT and eukaryotic DNA polymerases (such as human DNA polymerases alpha, beta, or sigma) are not inhibited by nevirapine. Nevirapine is, in general, only prescribed after the immune system has declined and infections have become evident. It is always taken with at least one other HIV medication such as Retrovir or Videx. The virus can develop resistance to nevirapine if the drug is taken alone, although even if used properly, nevirapine is effective for only a limited time.
Mechanism of actionNevirapine binds directly to reverse transcriptase (RT) and blocks the RNA-dependent and DNA-dependent DNA polymerase activities by causing a disruption of the enzyme's catalytic site. The activity of nevirapine does not compete with template or nucleoside triphosphates.
Route of administrationOral
  • Anti-HIV Agents
  • Anti-Infective Agents
  • Anti-Retroviral Agents
  • Antiinfectives for Systemic Use
  • Antiviral Agents
  • J05AR05
  • J05AG01
  • J05AR07
CAS number129618-40-2
Drug Info/Drug Targets: DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Knox C, Law V, Jewison T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS. Nucleic Acids Res. 2011 Jan; 39 (Database issue):D1035-41. | PMID:21059682